Top Markets
Coin of the day
Caladrius Biosciences, Inc. Caladrius Biosciences, Inc.

Caladrius Biosciences, Inc.

CLBS
Rankning i aktier #33297
Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical... Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical company primarily engaged in the development and commercialization of cellular therapies. These therapies aim to either reverse various diseases or stimulate the regeneration of compromised tissue. The company's pipeline includes several key investigational therapies: HONEDRA, which has received the prestigious SAKIGAKE designation, is undergoing Phase II clinical trials as a potential treatment for critical limb ischemia; XOWNA is currently in Phase IIb trials targeting coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy, is being evaluated for chronic kidney disease in patients prior to requiring dialysis. Previously known as NeoStem, Inc., the firm adopted its current name, Caladrius Biosciences, Inc., in June 2015. Established in 1980, the company maintains its corporate headquarters in Basking Ridge, New Jersey.
Aktiekurs
$0.4264
Senast synkroniserad: 2022-09-14
Marknadsvärde
$7.93M
Förändring (1 dag)
-16.44%
Förändring (1 år)
0.00%
Land
US
Handel Caladrius Biosciences, Inc. (CLBS)

Kategori

Historik för aktiesplit för Caladrius Biosciences, Inc. (CLBS)
Aktien Caladrius Biosciences, Inc. (symbol: CLBS) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 17, 2026.
En CLBS-aktie köpt före Aug 17, 2026 motsvarar nu 0 CLBS-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE